FIRST ANALYSIS NEWS
First Analysis Acted As the Exclusive Financial Advisor to CoverMyMeds
CoverMyMeds

CHICAGO – November 11, 2014 – First Analysis Securities Corporation ("First Analysis") acted as the exclusive financial advisor to CoverMyMeds LLC in its growth investment by Francisco Partners, one of the country's pre-eminent technology investors. CoverMyMeds, with offices in Columbus and Twinsburg, OH, is a leading healthcare technology company providing cloud-based software that automates the medication benefit process to reduce administrative waste while maximizing patient outcomes. The Company is a leader in the industry, providing healthcare IT solutions for more than 360 EHR systems, 45,000 pharmacy locations, and payers that represent 72% of U.S. prescription volume. More than 260,000 prescribers use CoverMyMeds' free software platform to ensure patients receive the medication they need to lead healthier lives.

First Analysis worked closely with the Company's management team throughout the process.

"First Analysis' Healthcare IT banking experience, extensive relationships and seasoned team were instrumental as we prepared for and negotiated our way through the process," said Ted Frank, CFO of CoverMyMeds. "The team went above and beyond to deeply understand our complex network-effect business, enabling First Analysis to partner with CoverMyMeds in a way that many banks promise, but few deliver. The result is an exceptional transaction with Francisco Partners, a firm that delivers as much in strategic value as it does in capital. Our goal is to create one of the strongest healthcare IT companies in business, and we look forward to working with Francisco Partners as we continue to positively impact care for millions of patients."

About CoverMyMeds

CoverMyMeds is a leader in the medication benefit process and one of the fastest growing healthcare information technology companies in the US. We help physicians, pharmacists, and their staff complete medication approval requests for any drug and all plans. The Company's technology integrates with payers, EHRs and pharmacy systems to create an efficient electronic process for all participants. For more information, visit www.covermymeds.com.


For more information about this transaction, or with questions about how we can assist you or your clients, please contact the following First Analysis representatives:

Matt Nicklin
Managing Director
mnicklin@firstanalysis.com
312-258-7181

Brian Friedman
Managing Director
bfriedman@firstanalysis.com
312-258-7110

Josh Moses
Vice President
jmoses@firstanalysis.com
312-258-7180

About First Analysis

Founded in 1981, First Analysis has over a 30-year track record of serving emerging growth companies and established industry leaders within its focused areas of domain expertise. Our investment banking practice leverages industry insights developed through our equity research and private equity activities to deliver value to clients across the life cycle of a business.

Providing senior-level attention to every client, First Analysis offers superior execution across a comprehensive range of investment banking services, including M&A advisory, public equity and debt financing, and private equity placements.

For additional information about how the investment banking professionals at First Analysis Securities Corporation can help you, please visit our website, www.firstanalysis.com, or call us at (312) 258-1400.


To download a pdf version of this press release, please follow the link below:
First Analysis Acted As the Exclusive Financial Advisor to CoverMyMeds

First Analysis Securities Corp. (FASC) is a registered broker/dealer with FINRA and member SIPC.

Investment banking and corporate finance services are offered through First Analysis Securities Corporation ("FASC" or "First Analysis Securities"), a subsidiary of First Analysis Corp.
©2020 by First Analysis Corporation.
One South Wacker Drive
  ·  
Suite 3900
  ·  
Chicago, IL 60606
  ·  
312-258-1400
First Analysis Securities Corp. (FASC) is a registered broker/dealer with FINRA and member SIPC.